Making Undruggable Targets Druggable,

Making Incurable
Diseases Curable.

Our Mission is to provide novel therapeutic strategies
for patients suffering with refractory diseases.
SCROLL DOWN
Science

TPD

TPD (Targeted Protein Degradation) technology has emerged as a novel therapeutic modality
that harnesses intracellular proteosomal and lysosomal protein degradation pathways for selective
elimination of pathological proteins.

Learn more
SCROLL DOWN
Science

SPiDEM™

Targeted protein degradation (TPD) is a novel platform technology in which
a small molecule selectively binds to a pathological protein and concurrently
activates the ubiquitin-proteasome system.

Learn more
SCROLL DOWN

Pipeline

We are developing novel therapeutics to treat viral infections and the
associated disease states.

Learn more
SCROLL DOWN

Our latest news

Prev Next